M&A

Pfizer nabs RSV therapeutic biotech ReViral in quick $525M bolt-on
Fierce Biotech
Thu, 04/7/22 - 10:29 am
Pfizer
RSV
M&A
ReViral
Pfizer's $6.7 Billion Bet Could Be About to Pay Off Big Time
Motley Fool
Wed, 04/6/22 - 11:52 am
Pfizer
M&A
Arena Pharmaceuticals
etrasimod
clinical trials
ulcerative colitis
Merck cuts 170 jobs at Acceleron right on heels of $11.5B buyout
Fierce Pharma
Wed, 03/30/22 - 11:05 am
Merck
Acceleron
M&A
layoffs
Cambridge
Eagle Announces Acquisition of Acacia in Strategic Good Fit
BioSpace
Mon, 03/28/22 - 10:11 am
Acacia Pharma
Eagle Pharmaceuticals
M&A
Sun Pharma forks over $485M to settle long-running legal battle inherited in Ranbaxy buyout
Fierce Pharma
Thu, 03/24/22 - 08:40 pm
Sun Pharma
legal
Ranbaxy
M&A
Fujifilm to acquire Shenandoah Biotechnology
Biopharma Reporter
Tue, 03/22/22 - 11:25 pm
Fujifilm
M&A
Shenandoah Biotechnology
drug discovery
recombinant proteins
Illumina sues Guardant CEOs over trade secrets, sparking counterblast against 'retaliatory' lawsuit
Medtech Dive
Fri, 03/18/22 - 10:46 am
Illumina
Guardant Health
trade secrets
legal
M&A
Grail
Sandoz bulks up ahead of possible sale with Coalesce buy
Pharmaforum
Mon, 03/14/22 - 10:21 am
Novartis
Sandoz
generics
M&A
Coalesce Product Development
MorphoSys cuts R&D from Constellation deal to focus on clinical-stage cancer drugs
MedCity News
Fri, 03/11/22 - 10:42 am
MorphoSys
drug discovery
R&D
Constellation Pharmaceuticals
M&A
Digging into biopharma’s big buyout areas
EP Vantage
Fri, 03/11/22 - 10:26 am
M&A
oncology
CNS
Rare Diseases
cancer
After slower-than-expected review, Pfizer and Arena to close buyout deal
BioPharma Dive
Thu, 03/10/22 - 10:24 pm
Pfizer
Arena Pharmaceuticals
M&A
GoodRx to acquire pharmacy services platform for $150M
Beckers Hospital Review
Tue, 03/8/22 - 10:04 am
GoodRx
M&A
VitaCare Prescription Services
digital pharma
Gilead says breast cancer drug succeeded in key study, but offers few details
BioPharma Dive
Mon, 03/7/22 - 10:52 pm
Gilead Sciences
Trodelvy
clinical trials
M&A
breast cancer
Rare disease and neurology take outs tick higher
EP Vantage
Wed, 03/2/22 - 10:03 am
M&A
AbbVie
AstraZeneca
Bristol Myers Squibb
JNJ
Gilead Sciences
Jazz Pharmaceuticals
Merck
Pfizer
Sanofi
rare disease
neurology
AbbVie bets $130M on UCB spinout, bagging early-phase Alzheimer's and depression prospect
Fierce Biotech
Tue, 03/1/22 - 10:42 am
AbbVie
M&A
Neuroscience
Syndesi Therapeutics
UCB Pharma
Alzheimer's disease
depression
Biocon buys Viatris biosimilars for $3.3bn, eyes IPO
Pharmaforum
Mon, 02/28/22 - 09:20 am
Biocon
India
Viatris
Mylan
biosimilars
M&A
Biohaven stocks up on experimental drugs with new acquisition, licensing deal
BioPharma Dive
Sun, 02/27/22 - 10:21 pm
Biohaven
Bristol Myers Squibb
Channel Biosciences
M&A
Justice Department sues UnitedHealth over nearly $8 billion deal to acquire tech company
Stat
Thu, 02/24/22 - 10:56 pm
Medtech
M&A
DOJ
Unitedhealth Group
Change Healthcare
Recipharm grows biologics business as it acquires Arranta Bio and Vibalogics
Biopharma Reporter
Fri, 02/18/22 - 10:28 am
Recipharm
biologics
M&A
CDMOs
Arranta Bio
Vibalogics
Baxter begins integrating Hillrom, faces supply chain pressures
Medtech Dive
Fri, 02/18/22 - 10:26 am
devices
Medtech
Baxter International
Hill-Rom
M&A
supply chain

Pages